Elanco Animal Health

NYSE: ELAN · Real-Time Price · USD
13.44
0.00 (0.00%)
At close: Jun 02, 2025, 3:59 PM
13.16
-2.08%
After-hours: Jun 02, 2025, 04:09 PM EDT

Elanco Animal Health Revenue Breakdown

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Cattle Revenue 1.01B 949M 944M 82M 80.2M
Cattle Revenue Growth +6.11% +0.53% +1051.22% +2.24% n/a
Contract Manufacturing Revenue 46M 42M 54M 2.33B n/a
Contract Manufacturing Revenue Growth +9.52% -22.22% -97.68% n/a n/a
Farm Animal Revenue 2.25B 2.27B 2.22B 2.35B n/a
Farm Animal Revenue Growth -0.92% +2.34% -5.61% n/a n/a
Pet Health Revenue 2.14B 2.1B 2.14B n/a n/a
Pet Health Revenue Growth +1.85% -1.59% n/a n/a n/a
Poultry Revenue 796M 765M 716M n/a n/a
Poultry Revenue Growth +4.05% +6.84% n/a n/a n/a
Swine Revenue 366M 382M 384M n/a n/a
Swine Revenue Growth -4.19% -0.52% n/a n/a n/a

Revenue by Geography

Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019 Dec 31, 2018
Non-Us Revenue 2.4B 2.43B 2.45B 2.64B 1.8B 1.55B 1.58B
Non-Us Revenue Growth -1.27% -0.49% -7.38% +46.91% +16.26% -2.36% n/a
United States Revenue 2.04B 1.98B 1.97B 2.12B 1.48B 1.52B 1.48B
United States Revenue Growth +2.67% +0.92% -7.49% +43.94% -3.22% +2.80% n/a

Operating Expense Breakdown

Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019 Dec 31, 2018 Sep 30, 2018 Jun 30, 2018 Mar 31, 2018 Dec 31, 2017 Sep 30, 2017 Jun 30, 2017 Mar 31, 2017
Selling, General, and Administrative Revenue 341M 300M 323M 354M 337M 292M 313M 353M 327M 303M 298M 343M 320M 329M 342M 385M 348M 374.1M 277.7M 162.8M 182M 185.9M 192.3M 200.9M 181.1M 185.1M 179M 191.1M 180M 196.8M 194.7M 194.2M 194.2M
Selling, General, and Administrative Revenue Growth +13.67% -7.12% -8.76% +5.04% +15.41% -6.71% -11.33% +7.95% +7.92% +1.68% -13.12% +7.19% -2.74% -3.80% -11.17% +10.63% -6.98% +34.71% +70.58% -10.55% -2.10% -3.33% -4.28% +10.93% -2.16% +3.41% -6.33% +6.17% -8.54% +1.08% +0.26% 0.00% n/a
Research and Development Revenue 94M 81M 87M 89M 87M 79M 86M 81M 81M 80M 78M 82M 81M 92M 94M 94M 89M 112.7M 88.1M 59.4M 66.8M 67.3M 69.9M 68.8M 64.1M 61.1M 58.9M 61.4M 65.2M 62M 61.9M 63.95M 63.95M
Research and Development Revenue Growth +16.05% -6.90% -2.25% +2.30% +10.13% -8.14% +6.17% 0.00% +1.25% +2.56% -4.88% +1.23% -11.96% -2.13% 0.00% +5.62% -21.03% +27.92% +48.32% -11.08% -0.74% -3.72% +1.60% +7.33% +4.91% +3.74% -4.07% -5.83% +5.16% +0.16% -3.21% 0.00% n/a